Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095236772> ?p ?o ?g. }
- W2095236772 endingPage "25657" @default.
- W2095236772 startingPage "25657" @default.
- W2095236772 abstract "Extracellular vesicles (EVs) are small nanometre-sized vesicles that are circulating in blood. They are released by multiple cells, including tumour cells. We hypothesized that circulating EVs contain protein kinases that may be assessed as biomarkers during treatment with tyrosine kinase inhibitors.EVs released by U87 glioma cells, H3255 and H1650 non-small-cell lung cancer (NSCLC) cells were profiled by tandem mass spectrometry. Total AKT/protein kinase B and extracellular signal regulated kinase 1/2 (ERK1/2) levels as well as their relative phosphorylation were measured by western blot in isogenic U87 cells with or without mutant epidermal growth factor receptor (EGFRvIII) and their corresponding EVs. To assess biomarker potential, plasma samples from 24 healthy volunteers and 42 patients with cancer were used.In total, 130 different protein kinases were found to be released in EVs including multiple drug targets, such as mammalian target of rapamycin (mTOR), AKT, ERK1/2, AXL and EGFR. Overexpression of EGFRvIII in U87 cells results in increased phosphorylation of EGFR, AKT and ERK1/2 in cells and EVs, whereas a decreased phosphorylation was noted upon treatment with the EGFR inhibitor erlotinib. EV samples derived from patients with cancer contained significantly more protein (p=0.0067) compared to healthy donors. Phosphorylation of AKT and ERK1/2 in plasma EVs from both healthy donors and patients with cancer was relatively low compared to levels in cancer cells. Preliminary analysis of total AKT and ERK1/2 levels in plasma EVs from patients with NSCLC before and after sorafenib/metformin treatment (n=12) shows a significant decrease in AKT levels among patients with a favourable treatment response (p<0.005).Phosphorylation of protein kinases in EVs reflects their phosphorylation in tumour cells. Total AKT protein levels may allow monitoring of kinase inhibitor responses in patients with cancer." @default.
- W2095236772 created "2016-06-24" @default.
- W2095236772 creator A5000622048 @default.
- W2095236772 creator A5011171028 @default.
- W2095236772 creator A5015860216 @default.
- W2095236772 creator A5016904876 @default.
- W2095236772 creator A5018213217 @default.
- W2095236772 creator A5022897881 @default.
- W2095236772 creator A5053700204 @default.
- W2095236772 creator A5057455457 @default.
- W2095236772 creator A5058944343 @default.
- W2095236772 creator A5064053465 @default.
- W2095236772 creator A5072034767 @default.
- W2095236772 creator A5072183451 @default.
- W2095236772 creator A5084043525 @default.
- W2095236772 date "2014-01-01" @default.
- W2095236772 modified "2023-10-11" @default.
- W2095236772 title "Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer" @default.
- W2095236772 cites W1762620449 @default.
- W2095236772 cites W1964232997 @default.
- W2095236772 cites W1966803171 @default.
- W2095236772 cites W1968094379 @default.
- W2095236772 cites W1987604193 @default.
- W2095236772 cites W1995991339 @default.
- W2095236772 cites W1997504014 @default.
- W2095236772 cites W2009412756 @default.
- W2095236772 cites W2016291232 @default.
- W2095236772 cites W2028415754 @default.
- W2095236772 cites W2030205108 @default.
- W2095236772 cites W2030701238 @default.
- W2095236772 cites W2043696829 @default.
- W2095236772 cites W2046758915 @default.
- W2095236772 cites W2054637102 @default.
- W2095236772 cites W2068191319 @default.
- W2095236772 cites W2076315676 @default.
- W2095236772 cites W2078594804 @default.
- W2095236772 cites W2080752012 @default.
- W2095236772 cites W2106490639 @default.
- W2095236772 cites W2109189228 @default.
- W2095236772 cites W2114032563 @default.
- W2095236772 cites W2115822788 @default.
- W2095236772 cites W2116731538 @default.
- W2095236772 cites W2117890823 @default.
- W2095236772 cites W2123391236 @default.
- W2095236772 cites W2125440931 @default.
- W2095236772 cites W2126640098 @default.
- W2095236772 cites W2128542677 @default.
- W2095236772 cites W2131687087 @default.
- W2095236772 cites W2133302300 @default.
- W2095236772 cites W2141569879 @default.
- W2095236772 cites W2155461614 @default.
- W2095236772 cites W2159801780 @default.
- W2095236772 cites W2167112360 @default.
- W2095236772 cites W2169491358 @default.
- W2095236772 doi "https://doi.org/10.3402/jev.v3.25657" @default.
- W2095236772 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4261239" @default.
- W2095236772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25491250" @default.
- W2095236772 hasPublicationYear "2014" @default.
- W2095236772 type Work @default.
- W2095236772 sameAs 2095236772 @default.
- W2095236772 citedByCount "28" @default.
- W2095236772 countsByYear W20952367722016 @default.
- W2095236772 countsByYear W20952367722017 @default.
- W2095236772 countsByYear W20952367722018 @default.
- W2095236772 countsByYear W20952367722019 @default.
- W2095236772 countsByYear W20952367722020 @default.
- W2095236772 countsByYear W20952367722021 @default.
- W2095236772 countsByYear W20952367722022 @default.
- W2095236772 countsByYear W20952367722023 @default.
- W2095236772 crossrefType "journal-article" @default.
- W2095236772 hasAuthorship W2095236772A5000622048 @default.
- W2095236772 hasAuthorship W2095236772A5011171028 @default.
- W2095236772 hasAuthorship W2095236772A5015860216 @default.
- W2095236772 hasAuthorship W2095236772A5016904876 @default.
- W2095236772 hasAuthorship W2095236772A5018213217 @default.
- W2095236772 hasAuthorship W2095236772A5022897881 @default.
- W2095236772 hasAuthorship W2095236772A5053700204 @default.
- W2095236772 hasAuthorship W2095236772A5057455457 @default.
- W2095236772 hasAuthorship W2095236772A5058944343 @default.
- W2095236772 hasAuthorship W2095236772A5064053465 @default.
- W2095236772 hasAuthorship W2095236772A5072034767 @default.
- W2095236772 hasAuthorship W2095236772A5072183451 @default.
- W2095236772 hasAuthorship W2095236772A5084043525 @default.
- W2095236772 hasBestOaLocation W20952367721 @default.
- W2095236772 hasConcept C104317684 @default.
- W2095236772 hasConcept C11960822 @default.
- W2095236772 hasConcept C121608353 @default.
- W2095236772 hasConcept C126322002 @default.
- W2095236772 hasConcept C145059251 @default.
- W2095236772 hasConcept C153911025 @default.
- W2095236772 hasConcept C184235292 @default.
- W2095236772 hasConcept C185592680 @default.
- W2095236772 hasConcept C20518536 @default.
- W2095236772 hasConcept C2776415932 @default.
- W2095236772 hasConcept C2778087573 @default.
- W2095236772 hasConcept C2779438470 @default.
- W2095236772 hasConcept C42362537 @default.
- W2095236772 hasConcept C502942594 @default.